Rio Tinto (LON: RIO) has attracted interest from more than a dozen potential bidders for its U.S. boron assets in California, which could fetch around $2 billion, accor

The FTSE 100 is up 0.2% on Friday morning, putting the index on track for a weekly gain of 1.9%. European markets are also broadly higher, with the FTSE 250 up 0.4%, Germany's DAX gaining 0.5% and France's CAC 40 edging up 0.

Shares of Impax Asset Management Group (IPX.L) plummeted more than 22% in early trading after the release of its Q2 AUM update. The specialist investor, focused on the transition to a more sustainable economy, reported a sign

Shares of B&M European Value Retail plc (BME) are under pressure today following the announcement of several leadership changes, creating uncertainty about the company's near-term direction.

Shares in AO World PLC (AO.) experienced a significant jump, climbing over 6% in early trading, after the release of its full-year post-close trading update for fiscal year 2026. The report highlighted robust revenue growth a

Unite Group (LON: UTG), the UK's leading student accommodation provider, released a Q1 2026 trading update, highlighting both resilience and strategic adjustments in a challenging market. While reservation rates for the 2026/

Zeus Capital welcomed ITM Power's (LON: ITM) £86.5 million UK government funding package as a significant positive for the electrolyser manufacturer in a note on Thursday following the announcement, arguing the combined equit

Citi upgraded Lloyds Banking (LON: LLOY) to buy from neutral in a note this week and raised its price target to 114 pence from 106 pence, saying it is "time to re-engage" with European banks as the interest rate outlook and e

The FTSE 100 is down 0.2% on Thursday morning as markets remain cautious amid signs that the Middle East ceasefire is already coming under strain, with Brent crude resuming its rise.

Foresight Group Holdings (LON: FSG) experienced a 4% share price decline following the release of its trading update for the financial year ended March 31, 2026. While the

Avacta Therapeutics (AIM: AVCT) shares experienced an uptick today following the release of its Q1 2026 business update, showcasing significant progress in its pre|CISION platform development.

Shares of Metlen Energy & Metals PLC (MTLN.L) experienced a modest gain of approximately 1.4% following the release of its FY 2025 financial results. While revenue dem

ITM Power (LON: ITM) saw its share price surge over 11% following the announcement of substantial financial support from the UK government. This includes a £40 million strategic investment by Great British Energy (GBE) and a

Hugo Boss (ETR: BOSS) is set to report a muted first quarter when it publishes results on May 5, with analysts at mwb Research warning that a deteriorating macro environment poses additional downside risk to the German fashio

Global stocks surged, and oil prices tumbled on Wednesday after a two-week ceasefire was agreed, with Iran agreeing to reopen the Strait of Hormuz, prompting UBS to lay out its investment playbook for the new backdrop.

The FTSE 100 has surged 2.6% on Tuesday morning as European markets rallied sharply following news of a two-week ceasefire in the war between the US and Iran. [stock_market_w

Zeus Capital reiterated its buy recommendation and 540 pence price target on Hunting (LON: HTG) shares following the precision engineering group's announcement of a $63.5 million subsea contract award for an offshore developm

Zeus Capital maintained its buy recommendation and 600 pence price target on Ashtead Technology (LON: AT.) in a note this week following the subsea services company's full-year 2025 results, reported on March 17, arguing the

Dr. Martens (LON: DOCS) shares experienced a moderate rise today following the announcement of a strategic restructuring. The company is shifting to a General Manager (GM) model for its major markets and establishing a new Ex

GSK plc (LSE/NYSE: GSK) experienced a modest share price increase of approximately 1% in early trading following the announcement that China's National Medical Products Administration (NMPA) has approved Exdensur (depemokimab